FDA approves Levaquin for plague
On April 27, the U.S. Food and Drug Administration approved Levaquin (levofloxacin) to treat patients with plague. The drug was approved under the agency’s…
Web Exclusives
A 200-year perspective on hospital costs and mortality
The New England Journal of Medicine has published an interesting article that traces mortality and hospital costs over 200 years at Massachusetts General Hospital,…
Analysis: Good communication enhances patient safety, satisfaction
A new report from HealthGrades finds that hospitals with the highest patient ratings in physician and nursing communications on average have fewer patient safety…
Joint Commission issues new requirements for health and wellness programs
The Joint Commission has issued new requirements for hospitals accredited for behavioral health care, which includes health and wellness promotion programs. These institutions must…
Marriage may promote happiness
Marriage doesn’t make people happier than when they were single, but it does protect against normal decline in happiness during adulthood according to a…
Physician supports APRNs in Atlantic article
John Rowe, a physician who is professor in the department of health policy and management at the Columbia University Mailman School of Public Health,…
CMS broadens ‘medical staff’ concept to include APRNs
The Centers for Medicare & Medicaid Services (CMS) has broadened the concept of “medical staff” so that hospitals can include other practitioners such as…
FDA approves Elelyso for Gaucher disease
On May 1, the U.S. Food and Drug Administration (FDA) approved Elelyso (taliglucerase alfa) for the treatment of Gaucher disease. Read more.
New abdominal surgical set clears FDA
On April 30, the U.S. Food and Drug Administration (FDA) announced that it is allowing marketing of the Percutaneous Surgical Set, the first instrument…
FDA approves Votrient for advanced soft tissue sarcoma
On April 26, the U.S. Food and Drug Administration (FDA) approved Votrient (pazopanib) to treat patients with advanced soft tissue sarcoma who have previously…
FDA warns of danger of ‘Japan Rapid Weight Loss Diet Pills Yellow’
The U.S. Food and Drug Administration (FDA) is advising consumers not to purchase “Japan Rapid Weight Loss Diet Pills Yellow,” which contains sibutramine and…
FDA approves new imaging agent to help identify AD
A study of hospital-acquired infections (HAIs) in the ICU presented at the 22nd European Congress of Clinical Microbiology and Infectious Diseases found that inpatient…
FDA approves Levaquin for plague
On April 27, the U.S. Food and Drug Administration approved Levaquin (levofloxacin) to treat patients with plague. The drug was approved under…
A 200-year perspective on hospital costs and mortality
The New England Journal of Medicine has published an interesting article that traces mortality and hospital costs over 200 years at Massachusetts…
Analysis: Good communication enhances patient safety, satisfaction
A new report from HealthGrades finds that hospitals with the highest patient ratings in physician and nursing communications on average have fewer…
Joint Commission issues new requirements for health and wellness programs
The Joint Commission has issued new requirements for hospitals accredited for behavioral health care, which includes health and wellness promotion programs. These…
Marriage may promote happiness
Marriage doesn’t make people happier than when they were single, but it does protect against normal decline in happiness during adulthood according…
Physician supports APRNs in Atlantic article
John Rowe, a physician who is professor in the department of health policy and management at the Columbia University Mailman School of…
CMS broadens ‘medical staff’ concept to include APRNs
The Centers for Medicare & Medicaid Services (CMS) has broadened the concept of “medical staff” so that hospitals can include other practitioners…
FDA approves Elelyso for Gaucher disease
On May 1, the U.S. Food and Drug Administration (FDA) approved Elelyso (taliglucerase alfa) for the treatment of Gaucher disease. Read more.
New abdominal surgical set clears FDA
On April 30, the U.S. Food and Drug Administration (FDA) announced that it is allowing marketing of the Percutaneous Surgical Set, the…
FDA approves Votrient for advanced soft tissue sarcoma
On April 26, the U.S. Food and Drug Administration (FDA) approved Votrient (pazopanib) to treat patients with advanced soft tissue sarcoma who…
FDA warns of danger of ‘Japan Rapid Weight Loss Diet Pills Yellow’
The U.S. Food and Drug Administration (FDA) is advising consumers not to purchase “Japan Rapid Weight Loss Diet Pills Yellow,” which contains…
FDA approves new imaging agent to help identify AD
A study of hospital-acquired infections (HAIs) in the ICU presented at the 22nd European Congress of Clinical Microbiology and Infectious Diseases found…
Poll
Preferred way to get content
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.